Gentris Corporation Announces Changes to Board of Directors

Dr. David Drutz Becomes Chair; Tim Gupton Joins Board

Morrisville, N.C. - Gentris Corporation (www.gentris.com), a global leader in applying genomic biomarkers to clinical studies, announced today that Dr. David J. Drutz will chair the Board of Directors. Dr. Drutz, who has had a distinguished career in medicine, pharmaceuticals, biotechnology, and venture capital, joined the Gentris Board a year ago. Tim Gupton, a highly experienced biopharma entrepreneur, and leader in accounting and finance, has also become a Board member.

 Click Here to View the Full Press Release